PG

Prasad Ganpatrao Anaokar

Director Director DIN 02903259
DIN 02903259 First appointment Dec 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2009
Shareholding value •••• Premium profile

About Prasad Ganpatrao Anaokar

Data last updated:

Prasad Ganpatrao Anaokar was a Director at Gangwal Chemicals Pvt Ltd (2009–2022) and Additional Director at Gangwal Healthcare Private Limited (2021–2022). The companies operate in Pharma and FMCG.

DIN 02903259
Primary Designation Director
Industry Pharma
First Appointment 24 Dec 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gangwal Chemicals Pvt Ltd U24110MH1987PTC045235
Director24 Dec 20091987₹23.32 Cr (FY 2024)Active
Gangwal Healthcare Private Limited U85300MH2021PTC359879
Additional Director17 May 20212021₹117 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gangwal Chemicals Pvt Ltd
Gangwal Healthcare Private Limited
Premium access

Shareholding and investment profile for Prasad Ganpatrao Anaokar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prasad Ganpatrao Anaokar

Prasad Ganpatrao Anaokar was first appointed on 24 Dec 2009 as Director at Gangwal Chemicals Pvt Ltd. The most recent appointment on record is 17 May 2021 at Gangwal Healthcare Private Limited.

Prasad Ganpatrao Anaokar held 2 earlier board appointments: Gangwal Chemicals Pvt Ltd (Director, 24 Dec 2009 to 31 Jan 2022); Gangwal Healthcare Private Limited (Additional Director, 17 May 2021 to 30 Sep 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available